← Leaderboards
Tamara Beth Horwich
University Of California Los Angeles
$449,541
Attributed
$449,541
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $113K · FY2006–10$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$449,541 · 6
By mechanism
K23$432,000 · 1
M01$17,541 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Kalyanam Shivkumar$14,865,442
- James N Weiss$19,803,040
- Peng-Sheng Chen$18,656,098
- Zhilin Qu$9,411,498
- Gang Li$6,759,409
Others in their field
Top investigators on “Institution”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,187,810,557
- Leonard Freedman · Leidos Biomedical Research, Inc.$835,530,754
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$566,554,288
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
InstitutionHeart FailureRandomizedResearch PersonnelCardiacDouble-Blind MethodQuality Of LifeNerveStructureSymptomsClinical ResearchBiomathematicsAreaBrain Natriuretic PeptideBiomarkerBiological MarkersApoptoticAbstractingChemosensitizationBeta-ChemokinesChemokineCholesterolChronicCharacteristics
Grant awards (9)
Statins in Non-Ischemic Heart Failure: Potential Mechanisms of Benefit$108,000
K23 · FY2010 · HL · contact PI
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE-CENTER STUDY TO ASSESS$659
M01 · FY2010 · RR · contact PI
Statins in Non-Ischemic Heart Failure: Potential Mechanisms of Benefit$108,000
K23 · FY2009 · HL · contact PI
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE-CENTER STUDY TO ASSESS$3,879
M01 · FY2009 · RR · contact PI
Statins in Non-Ischemic Heart Failure: Potential Mechanisms of Benefit$108,000
K23 · FY2008 · HL · contact PI
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE-CENTER STUDY TO ASSESS$4,991
M01 · FY2008 · RR · contact PI
Statins in Non-Ischemic Heart Failure: Potential Mechanisms of Benefit$108,000
K23 · FY2007 · HL · contact PI
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE-CENTER STUDY TO ASSESS$4,809
M01 · FY2007 · RR · contact PI
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE-CENTER STUDY TO ASSESS$3,203
M01 · FY2006 · RR · contact PI